How can analyses of costs and cost-effectiveness help international health care specialists to monitor service delivery, evaluate activities, plan for improvements in programmes, and arrange for adequate financing? Answers illustrated in this paper include comparison of the average costs of specific services among local health care facilities for monitoring and supervision purposes; interpretation of total and average costs to increase programme efficiency; consideration of the relative cost-effectiveness of various immunization strategies; projection of recurrent costs to indicate the magnitude of future financing needs; and, derivation of information incidental to cost analyses, but essential to programme operations and personnel management. Supportive examples include results from child survival programmes in Africa, with particular emphasis on evaluations of some national programme components from the Combatting Childhood Communicable Diseases (CCCD) Project.
Introduction
Economic information and insights are much in demand these days for planning, administering, and financing preventive health care programmes in developing countries (Gilson 1987) . Economists' techniques of programme evaluation are varied, and have been presented well in literature accessible to health care officials, development assistance personnel, and consumer advocates (e.g., Mills 1985, Mills and Thomas 1984) . Analyses of costs and of costs in relation to effects, such as the impact of preventive health care services on health status, are notable examples of those techniques; they represent the focus of this paper which responds to a question posed in a recent article, 'Why do costings?' (Phillips 1987) . Our theme can be summarized in a question: 'How can analyses of costs and costeffectiveness help international health care specialists to monitor service delivery, evaluate activities, plan for improvements in programmes, and arrange for adequate financing?'
There are many constructive answers to that question. Among those to be found in this paper are: comparison of the average costs of specific services among different local health care facilities of a nation for monitoring and supervision purposes; interpretation of total and average costs by evaluators and policy officials to increase programme efficiency; consideration of the relative cost-effectiveness of various immunization strategies; projection of costs, especially recurrent ones, to indicate the magnitude of future financing needs; and, derivation of information incidental to cost studies but essential to programme operations and personnel management, such as the value of vaccine wastage rates and employee supplementary benefits. For illustrations of studies demonstrating these uses, we have concentrated on results from child survival programmes in Africa, including evaluations of some national programme components from the Combatting Childhood Communicable Diseases (CCCD) Project. Funded by the US Agency for International Development (USAID) and implemented by the Centers for Disease Control (CDC), the CCCD Project emphasizes three categories of childhood diseases -vaccine preventable diseases, acute diarrhoeal diseases, and malaria -and delivers preventive health care services to children under the age of five in Africa. Despite this regional and programme orientation, we believe that the selections apply throughout the developing world.
Given our focus on 'cost,' that term must be defined first. 'The cost of something is the total monetary value ... of all resources used to produce it' (Robertson 1985b:2) . It refers to the supply of health care services by providers and not to consumers' demand for them or to prices charged. 'Demand-side' costs, such as those incurred by consumers to obtain health care services, require extensive survey information; the merits of the supply-based cost measures used here will be evident in the cases below.
In the material that follows, readers will see the usefulness (actual or potential) of information concerning: the total costs of a programme and their disaggregation among resource inputs; the average costs of various components of a programme and certain factors affecting them; the relationship between costs and particular effects (or 'cost-effectiveness'); and, finally, other results or 'by-products' of cost studies together with the implications of findings and of data gaps for improved health information systems.
Total costs and their distribution among sources of funds and types of inputs
Description of the total volume of resources, in terms of total costs, needed for implementation of a developing country health care programme can be used by policy makers, finance officials, and staff members of external assistance organizations (both public and private) to show the value and quantity of resources required, and to project future costs for budget-making purposes. As total costs are disaggregated, for example among categories of resource inputs, additional uses are evident, including for cost control.
Overall total costs are well illustrated by the CCCD Project in Swaziland and Malawi, as they were studied using very similar methods for their first nine months of operation in 1984-85 (Robertson and Quails 1985 , Robertson 1985a , methodology based on WHO 1979 . National totals, shown in Table 1 , were derived for the 
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Malawi - Robertson, 1985a , Tables 3-6 . Swaziland - Robertson and Quails (1985) , Tables 3-6 . Population -1983 preliminary estimates from World Bank, 1985: 6-9 (in thousands: 6670 for Malawi, 688 for Swaziland).
programme components of immunization (EPI), diarrhoeal disease treatment (ORT), and malaria therapy from central and regional level sources and from extrapolations of sampled local health care facilities' data. They show the value of resources from all sources (including contributions) required as recurrent and capital inputs early in the history of these child survival programme components. Naturally, those requirements could change as the programme components mature (Westinghouse 1986a). Clearly, the CCCD Project was larger or more costly in Malawi for each programme component and in total.
Although the national total cost is interesting in its own right for showing full resource needs to budget makers, perspective on its size and on its possible burden to the country is added by expressing it in per capita terms. Disaggregating total costs in several ways can add to their usefulness. Developing country health care officials and external assistance staff can gain from distributing total costs among sources of funding for their programmes. As argued by a UNICEF staff member, one of the benefits to be gained from a division between nationally budgeted and externally contributed funds (or real resources) is the estimation of the 'multiplier effect' of contributions, that is, the factor of expansion in total spending on health resulting from external assistance (Parker 1987 ). An approach to that benefit can be illustrated by the Swazi CCCD study results which showed that contributions by UNICEF and a special USAIDfunded media campaign alone accounted for one-seventh of total Project costs (Robertson and Quails 1985 : Tables 1 and 6 ).
Information on the sources of funding also supports assessments of a nation's capacity to sustain its programmes when outside aid is no longer provided (Parker 1987; USAID 1986:99) . National CCCD external evaluation teams drew upon the preceding cost studies of Swaziland and Malawi to reach conclusions concerning sustainability (Westinghouse 1986a and 1986b) . According to a recent CCCD annual report, contributions to knowledge and policy determination for sustainability include at least nine cost recovery studies (USAID c.1987 ). To compare the distribution of resource inputs within immunization programmes, two African countries with diverse delivery modes, The Gambia and Mauritania, are considered in Table 2 . The Gambian EPI programme in 1981-82 was integrated with the maternal and child health programme; services were delivered by teams working full-time on certain days at fixed bases and on other days travelling to outlying villages or health posts on regular schedules (Robertson et al. 1984) . Its methodology was similar to that for the CCCD studies. In Mauritania, three strategies of immunization were tried at various times during 1985-86: routine services at fixed sites, intermittent local visits by mobile teams, and special vaccination days within a campaign that had three-day rounds (Brenzel 1986 ). The percentage shares in the cost profile shown for the single delivery strategy of The Gambia were to be expected; for example, the figure for personnel was similar to that found in earlier studies elsewhere, and transportation was appreciable where extensive outreach was involved. However, the shares for Mauritania revealed some surprises, even after making allowances for intrinsic differences in strategies. The fixed site personnel percentage of 15 was very low in comparison with other countries, though offset in part by the substantial cost of buildings. The latter category, in contrast, was negligible as estimated for the mobile teams, though some facilities must have been occupied. The campaign strategy's distribution raised several questions for investigation by the nation's EPI officials and health planners. For example, it was surprising for a short-time campaign with wide geographic spread to have only 12% of the total costs for transportation, and it was even less to be expected that promotional media efforts for the special days incurred just 5% in view of 
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findings from other campaigns. However, its training share was quite large. Thus, the cost profile for Mauritania may indicate something important about the internal organization of the national health care system.
Comparison of the cost profiles for the full CCCD Project of Malawi and Swaziland and of specific local health care facilities within those countries would indicate major differences in personnel costs, serving as a starting point for analysis of factors affecting labour costs and their control by administrators and finance or economic specialists. Various disaggregations of findings demonstrated that personnel costs in Malawi were not as appreciable as in Swaziland. As surmised by several Malawian health care officials, comparatively low salary scales contributed to the differences. It was suggested that the use of different levels of health care personnel to provide CCCD services might have influenced costs. This did not appear to be true of physicians at the local health care facilities sampled in Malawi and Swaziland who were used about equally heavily, but it might have been a contributing factor with respect to certain less trained health care personnel at smaller facilities. Additional data, interpreted with caution, concerning comparative labour productivity would have been required to investigate these cost differences still further and to identify the most efficient staffing modes of delivering services in relation to the prevailing health conditions. Total costs can be disaggregated in other waysnotably through a division between fixed and variable costs, based on whether or not total costs change as the volume of services increases. Making this distinction can help health care administrators and planners, together with finance officials, to determine the effect of externally paid expatriate personnel on real project start-up costs, consider the redistribution of staff members among local health care facilities for better coverage and greater efficiency, estimate the marginal (incremental) costs of expanding an entire programme or a component of it and, assess future demands on resources and the fiscal sustainability of these activities in their country. A cost study of immunizations in The Gambia showed the importance of expatriate personnel costs -60% greater than the total of all other personnel -and noted the role of fixed costs when analysing the possibilities for cost savings through redeployment of EPI personnel, by changing staffing patterns or catchment areas of local delivery units (Robertson et al. 1984) . The authors' judgment that certain inputs were variable instead of fixed in the short-run affected the personnel deployment options open to Gambian policy makers. Their assumptions that local health care personnel costs were variable followed that of pioneering EPI studies (Creese et al. 1982) and others (e.g., Phillips et al. 1987) .
Average costs and their interpretation
After total costs have been found, average costs can be estimated to the extent that adequate information exists on the volume of services provided. The results of average cost estimations and interpretations can be used by health care officials at all levels to allocate scarce resources more efficiently among alternative uses, through the identification of distinctive high-and lowcost local health care facilities for possible correction or emulation. Improvements in efficiency -that is, reductions in average costs without sacrifice of quality of care or of equity in distribution of services among patients -are crucial to expanding the nation's sustainable volume of health care services. These achievements will have obvious interest for external parties as well as nationals.
As a first attempt at average cost analysis, health care administrators and planners may (with caution) examine their nation's overall cost per dose for immunizations or per case treated for diarrhoeal disease or malaria in relation to findings from studies in other countries having similar programmes. For example, Malawi had very low average costs for its EPI component of the CCCD Project. The national cost per immunization dose of just under one US dollar ($0.99) put it below countries such as Swaziland ($2.58) and The Gambia ($1.09 excluding expatriate costs or $1.75 including them, for an earlier period) (Robertson 1985a , Robertson and Quails 1985 , Robertson et al. 1984 . Additional data for comparisons can be found in several review papers containing African and other case findings (Creese et al. 1982; Haaga 1986 , Robertson 1985b , Brenzel 1986 ). Intranational cost comparisons might prove even more useful. To illustrate, cost per immunization administered can be compared for the three delivery strategies of the CCCD Project in the Congo in 1985: the EPI, based primarily in urban fixed centres (maternalchild health centres and dispensaries); Grandes Endemies, working from fixed centres at ten operational headquarters and providing limited mobile outreach to surrounding districts; and, the Mossendjo-based CARE-Congo Primary Health Care Project, working from fixed centres and providing intensive mobile outreach to outlying villages. For the EPI, cost per immunization for fixed centres located in Brazzaville was estimated to be $US1.42 for the six-month period January-June 1985; for Grandes Endemies, cost per immunization for fixed centres at operational headquarters was $1.06 for the five-month period January-May 1985; and, for CARECongo, cost per immunization was $0.78 for the overall immunization programme for the sixmonth period January-June 1985 (average costs were $0.56 and $0.86 for fixed centres and intensive mobile outreach services, respectively) (Quails 1985 and Certain 'outliers' revealed by those tabulations merit further examination by local health care administrators and their supervisors to explain their extreme results. It is interesting that the two high-side facilities might yield different judgements from such investigations. Sitobela rural health centre had the highest Swazi costs for both EPI and ORT components -clearly calling for explanation and justification. For Malawi, the high K 12.96 cost of diarrhoeal disease at Nankhumba dispensary was not accompanied at "Total cost is slightly understated due to omissions, so average cost is slightly understated for this site.
•Total counts of cases for the nation are not available, so average cost cannot be computed for it. Source: Robertson (1985a) , adapted from Tables 4 and 12. Robertson and Quails (1985) , adapted from Table 12. at Pennsylvania State University on September 18, 2016 http://heapol.oxfordjournals.org/ Downloaded from the same site by excessive average costs for immunizations and malaria treatments; the facility appeared simply to have provided a remarkably low volume of ORT services in relation to its fixed costs.
The immunization component of the CCCD Project has been quite thoroughly studied at the local level, where the results can point health care administrators to unusual as well as typical cases and can help finance specialists to set budgetary targets for health care officials. Local site experiences of the CCCD Project are found in Table 4 -A for 18 Malawi sites and Table 4 -B for 17 Swaziland sites. What can be learned from these tables in order to point health care officials to further site-by-site analysis?
Average costs of the EPI were computed for 18 of the 24 delivery sites analysed in Malawi, although limitations to the data (especially for the number of immunizations) should be noted.
The range of average costs in Table 4 -A was quite wide for the 18 sites; the two lowest values (K0.15 and K0.16 or about SUS0.10) were extremely low and should be rechecked by health care administrators (especially for the total cost numerators of the average) before being accepted. Still, several other delivery sites had plausible values well below the national average of K1.52, which itself was not high, while a few were relatively high. At the upper end, the K6.31 (SUS4.12) unit cost at the Nkhata Bay District Hospital warranted further examination by staff to explain its size. Was relatively low utilization involved and why? Could higher quality of providers at the hospital have affected its costs? About the only generalization to be made from these results was that health centres (dispensaries) usually operated more cheaply than larger facilities, although the nation's largest hospital (Queen Elizabeth, with a value of K0.86 or SUSO.56) offered a major exception to that observation. Overall, one might conclude that more intensive use of delivery facilities tends to lower "Number of doses is understated so average cost is overstated to an unknown degree for this site.
Source: Robertson and Quails (1985) , adapted from For the CCCD programme components covered here, the potential for higher volume to yield lower average costs due to the existence of appreciable fixed costs is best seen for Malawi's EPI component. It is even better revealed in the findings of the earlier Gambian EPI study, which showed a clear inverse relationship between average cost per immunization dose and service volume for the 13 field units providing comparable services (their costs varied from SUS0.41 to $2.32 a dose, while number of doses per session ranged from 273 to 44). It seemed that the optimum service volume (corresponding to the lowest average cost) had not yet been reached in the field units, because the average cost curve continued to fall throughout the range of service volumes in the study sample (Robertson et al. 1984) . Policy implications for review included reductions in frequency of visits for mobile 'trekking' sessions (but with possibly adverse effects on coverage and continuity), expansion of catchment areas (with similar threats to coverage), and experiments with different configurations of delivery personnel (which might or might not reduce total costs without undue cuts in service volumes or quality).
Cost-effectiveness results
The value of cost data is enhanced when estimates can be made to show what is obtained for the resources used and costs incurred. An important economic approach to this process is costeffectiveness analysis, which relates programme costs to one or more desirable effects. Indicators of cost-effectiveness include cost per fully vaccinated child (based on vaccination coverage data), and cost in relation to health status improvements as measured by cost per disease case and death averted and by cost per year of healthy life saved through some intervention (Mills and Thomas 1984) . Although these analyses make fairly heavy demands on data collectors (Reynolds and Gaspari 1985) and should not be taken as the only bases for decisions on resource allocation, they can be useful to policy makers and health care administrators in increasing the efficiency of ORT activities, as argued at ICORT-II (USAID 1986), of EPI (Creese and Henderson 1980) , and of other interventions to promote child survival. This position was endorsed in a recent invited lecture by a prominent Nigerian physician (Onuigbo 1987).
To relate cost to vaccine coverage, WHO in the past recommended the indicator of cost per fully vaccinated child (FVC), formerly called 'fully immunized child' (FIC) (WHO 1979) . Due to its limitations, some controversy exists as to the appropriateness of using cost per FVC to compare the cost-effectiveness of immunization programmes. However, cost per FVC continues to be used officially, and it can be shown to measure cost-effectiveness. No generally accepted measure of partial immunization status is available to apply here instead. Despite the usual problems of making international comparisons, including the difficulty of determining realistic currency exchange rates, a nation's EPI administrators and even external parties can be helped in appraising their programme by comparing its cost per FVC with other countries' values. Good summaries of results exist, showing figures in 1982 price terms that include SUS9.50 for Cameroon, $12.00 for The Gambia, $16.60 for Kenya, and much higher costs for Ghana , Creese 1986 ). Costs for full coverage varied from $6.83 to$17.37 in 1985 for three different immunization strategies in Mauritania (Brenzel 1986 ). Most show more costly resource requirements to achieve FVC status than the figure of about $10.00 usually estimated by supporters of child survival programmes (Wolff c. 1986 ). Nevertheless, comprehensive immunization programmes are probably sustainable in view of the high priority currently given to EPI.
Against these values the comparable findings for the CCCD programme components in Malawi and Swaziland during 1984-85 can be placed: $US11.48 and $50.57, respectively (Robertson 1985a, Robertson and Quails 1985) . Both of these costs per FVC probably will fall as per dose values drop with expansion and stabilization of EPI activities (Westinghouse 1986a and 1986b) . The Malawian figure is already comfortably within the range of typical African values, but the Swazi one clearly is on the high side. In comparison with Malawi, Swaziland had an appreciably higher cost per dose ($US2.58 versus $0.99) and a greater number of doses required on average for full vaccination status (19.6 versus 11.6). Swazi officials apparently have taken prompt action to remedy the latter deficiency; more recent data show considerably improved immunization coverage, with an increase for 1984 to 1986 of full vaccination status from about 22 to 39% (USAID c.1987 , Westinghouse 1986b . This inevitably has reduced the average doses needed for full vaccination status and hence the cost per FVC.
Pure 'cost-effectiveness' potentially covers more than immunizations. In fact, any health care intervention whose health status improvements (or other desirable effects) can be estimated is subject to analysis in those terms. It is well known that effects are difficult to estimate -for example, for ORT -when the service is provided as one part of a comprehensive health care programme like the CCCD Project (USAID 1986). Still, some successful cost-effectiveness studies of primary health care have been done; a good example concerned mobile health services in Botswana Walker and Gish 1977) . Certain others are covered in a recent review paper (Mills 1985) .
Difficulties in estimating outcomes explain the fact that cost-effectiveness analyses are most Hkely to be accomplished for immunizations whose impact on health status can be estimated with reasonable precision. Surveys show some of these results, with emphasis on Africa, expressed in terms of disease cases and deaths averted (Haaga 1986) . Published reports of two African studies can be consulted for their detailed findings and policy implications Shepard et al. 1986 ) Results vary among diseases as well as countries.
No one would contend that such research should be the only guide to resource allocation in the health field. It can, however, give planners and decision makers information to supplement noneconomic considerations when policies are formulated and implemented. Administrators' capacity to meet demands for accountability also can be enhanced with better data. Viewed comparatively, study results can indicate the relative efficiency of health care interventions, suggesting possible improvements in programmes and choices among alternative delivery strategies. Studies of a programme that are replicated over time can show whether it has become more or less cost-effective -useful information for an on-going monitoring process. Cost-effectiveness analysis alone 'is not a sufficient criterion for evaluating complex medical care programmes,' but it can be useful for promoting better health (Berman 1982 (Berman :1056 .
By-products of cost studies
Cost studies of health care programmes for child survival in developing countries can provide useful 'by-products,' or unexpected data and ideas that may inform health care officials about various aspects of programme operation and effectiveness. They also can reveal needs for additional information on costs and other performance variables to improve health service record keeping and delivery through better management. Another by-product of some cost studies has been the estimation of the value of supplemental employee benefits or the identification of data gaps for doing that. Benefits, such as housing provided to staff members, can influence employee recruitment and job satisfaction considerably. Knowledge of the real cost of benefits -especially those provided in kind, that is, as goods or services rather than cash -can be useful to personnel officers and budgetary officials, as well as to those who make decisions on compensation policies. The cost study in Malawi found a gap in information at the central level of government; it concerned the real cost in marketvalue terms of housing that was made available to some public employees, including those in health, who paid rents equal to approximately 10% of their salaries, thus paying at below market rates. No estimates of the true costs of this potentially large programme had been made or could be readily done, so the cost study report suggested an approach to estimating the values 'if governmental authorities agreed on the need for them' (Robertson 1985a:27) .
Identification of information gaps can be an important by-product of work on costs. For example, Malawi, with its larger number of health care facilities and patients served, had more severe data limitations on service volumes than Swaziland, while its bases for estimating uses of staff time were better. Problems with the completeness and timeliness of local utilization reports highlighted the difficulties of generating national volume summaries for Malawi. The CCCD cost study gave impetus to the efforts already being made by central statisticians and possibly encouraged high-level health care administrators to seek faster reports and a computerized approach to national summarization of experience regarding immunizations, diarrhoeal disease treatments, and other child survival interventions. Those improvements could lead in turn to further expansion of the entire health information system.
Conclusions
In this paper, we have tried to identify and illustrate many potential uses of cost analyses for a variety of parties in the health field of developing countries. Health care facility managers and their supervisors, for example, can learn to make necessary local adjustments when a programme's average costs at various facilities are compared. They can be pointed to factors such as staffing patterns that affect costs. Personnel officers and employees can gain from better estimation of the value of certain supplementary benefits. The work of health information specialists can be enhanced by independent information on data gaps and recommendations for improved cost information systems. Finance personnel, including those responsible for budgets, can learn from many aspects of cost studies and related costeffectiveness analyses, including finding ways to reduce programme costs and projecting future demands on resources as part of assessing the fiscal sustainability of programmes; international and bilateral assistance organizations as well will be concerned with the affordability of future activities. Health planners can find interventions and strategies that offer more beneficial effects for the inputs required, and can better monitor programmes over time.
All of these and other benefits of applied research on costs are potentially useful to policy makers in national governments, as well as in private agencies and external assistance organizations, for making decisions to improve health care in the developing world. A wide range of policies concerning programme management, selection of activities and their distribution among locales and populations, and financing of health services can be influenced for the better when these officials base their decisions on the results illustrated here.
This paper includes a limited number of actual uses of the results of cost analyses. However, it does not purport to be a full review of the acceptance in practice of such work. Descriptions of responses in developing countries and assessments of the conditions that favour acceptance might constitute the scope of a new paper, casting further light on a continuous process.
'Health is too important to be left to the economists,' of course, but the results of cost analyses and other elements of economic evaluation can be useful in the field. In a world beset by major problems threatening the survival of many children and the health of all, the challenge to use scarce resources better is great. It can and must be met.
